| Schedule of Segment Information |
Selected financial information for the Company’s
operating segments is as follows:
| |
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
| |
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
| Net revenues - External |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hospital Operations |
|
$ |
4,055,774 |
|
|
$ |
3,177,481 |
|
|
$ |
9,161,039 |
|
|
$ |
4,733,556 |
|
| Clinical Laboratory Operations |
|
|
5,415 |
|
|
|
114,736 |
|
|
|
90,800 |
|
|
|
160,321 |
|
| |
|
$ |
4,061,189 |
|
|
$ |
3,292,217 |
|
|
$ |
9,251,839 |
|
|
$ |
4,893,877 |
|
(Loss) income from continuing operations
before income taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hospital Operations |
|
$ |
(4,002,213 |
) |
|
$ |
(1,231,764 |
) |
|
$ |
(7,177,320 |
) |
|
$ |
(2,704,363 |
) |
| Clinical Laboratory Operations |
|
|
(180,028 |
) |
|
|
(462,271 |
) |
|
|
(405,558 |
) |
|
|
(1,218,354 |
) |
| Corporate |
|
|
(914,074 |
) |
|
|
(699,350 |
) |
|
|
(1,986,909 |
) |
|
|
(2,182,691 |
) |
| Other income (expense), net |
|
|
(8,183,261 |
) |
|
|
47,857,883 |
|
|
|
(16,642,584 |
) |
|
|
(95,216,393 |
) |
| |
|
$ |
(13,279,576 |
) |
|
$ |
45,464,498 |
|
|
$ |
(26,212,371 |
) |
|
$ |
(101,321,801 |
) |
| Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hospital Operations |
|
$ |
176,371 |
|
|
$ |
99,991 |
|
|
$ |
350,147 |
|
|
$ |
137,717 |
|
| Clinical Laboratory Operations |
|
|
9,683 |
|
|
|
217,495 |
|
|
|
59,345 |
|
|
|
512,969 |
|
| Corporate |
|
|
182 |
|
|
|
248 |
|
|
|
330 |
|
|
|
562 |
|
| |
|
$ |
186,236 |
|
|
$ |
317,734 |
|
|
$ |
409,822 |
|
|
$ |
651,248 |
|
| Capital expenditures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hospital Operations |
|
$ |
1,398 |
|
|
$ |
- |
|
|
$ |
43,715 |
|
|
$ |
- |
|
| Clinical Laboratory Operations |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| |
|
$ |
1,398 |
|
|
$ |
- |
|
|
$ |
43,715 |
|
|
$ |
- |
|
| |
|
As of |
|
| |
|
June 30, 2019 |
|
|
December 31, 2018 |
|
| Total assets |
|
|
|
|
|
|
|
|
| Hospital Operations |
|
$ |
16,257,398 |
|
|
$ |
13,568,933 |
|
| Clinical Laboratory Operations |
|
|
425,167 |
|
|
|
271,426 |
|
| Corporate |
|
|
2,687,282 |
|
|
|
2,707,416 |
|
| Assets of AMSG and HTS classified as held for sale |
|
|
318,854 |
|
|
|
152,171 |
|
| Eliminations |
|
|
(2,760,506 |
) |
|
|
(2,500,646 |
) |
| |
|
$ |
16,928,195 |
|
|
$ |
14,199,300 |
|
|